Gilead Sciences will release Fourth Quarter and Full Year 2022 Financial results on Thursday, February 2, 2023

FOSTER CITY (Calif.), January 19, 2023–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2022 financial results and full year 2023 financial guidance will be released on Thursday, February 2 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s fourth quarter and full year 2022 financial results and provide a business update.

The Investor Relations section will have a live webcast. www.gilead.com These documents will be archived for one year.

About Gilead Sciences

Gilead Sciences, Inc., is a biopharmaceutical business that has achieved medical breakthroughs for more than 30 years. The company’s goal is to make the world a better place for all. The company is dedicated to developing innovative medicines to treat life-threatening illnesses, such as HIV/Viral Hepatitis, and cancer. Gilead has a headquarters in Foster City in California and operates in over 35 countries.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.comFollow Gilead Sciences on Twitter (@GileadSciences), or call Gilead Public Affairs (1-650-574-3000)

Businesswire.com – View the source version https://www.businesswire.com/news/home/20230119005621/en/

Contacts

Jacquie Ross, CFA – Investors
[email protected]